ADVERTISEMENT
Why Indian Units Of Pharma MNCs Are Emerging As A Safe Bet For Investors
What makes pharma MNCs the defensives for India’s stock markets.
19 Dec 2019, 12:17 PM IST
Listed subsidiaries of foreign drugmakers have outperformed their domestic peers and the benchmark Nifty Pharma Index this year on the back of new product launches and the government’s push for affordable healthcare.That came as India’s largely export-oriented domestic drugmakers face headwinds in key markets, including the U.S. and western Europe, because of regulatory hurdles, price erosion, competition and litigation.
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT